Investigating Patients’ Preferences to Inform Drug Development Decisions: Novel Insights from a Discrete Choice Experiment in Migraine

Aleksandra Torbica, Carla Rognoni and Rosanna Tarricone
Additional contact information
Aleksandra Torbica: CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy
Carla Rognoni: CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy
Rosanna Tarricone: CERGAS (Centre for Research on Health and Social Care Management), SDA Bocconi School of Management, Bocconi University, 20136 Milan, Italy

IJERPH, 2021, vol. 18, issue 9, 1-18

Abstract: There is limited evidence on the scope and overall benefit of patient-centred drug development decisions. The present study assessed patients’ preferences for the characteristics of an ideal migraine treatment through a discrete choice experiment in order to inform decision-making and drug development processes. We investigated the preferences according to five treatment attributes identified from a systematic literature review and two focus group elicitations. The heterogeneity of preferences was also investigated. Overall, the respondents considered the presence of adverse events, duration of treatment effect, reduction of symptom intensity, speed of effect and cost born by the patient as the most relevant treatment features. As expected, the patients preferred treatments with lower levels of adverse events and costs and treatments with greater speed, duration of treatment effect and effectiveness in reducing symptom intensity. There was significant preference heterogeneity only for the presence of adverse events. Compared to men, women had significantly higher preferences for quicker treatment effect and limited adverse events and reported higher preferences for costly treatments. The results of our survey help address research and development strategies in the pharmaceutical industry and public policy regarding treatments that are clinically effective and responsive to the needs expressed by patients.

Keywords: migraine; discrete choice experiment; patients’ preferences; treatment characteristics (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/9/4916/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/9/4916/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:9:p:4916-:d:549015

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().